{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:20:35Z","timestamp":1788466835031,"version":"build-2803163510"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Combined oral contraceptives (COCs), oral contraceptives containing an estrogen and a progestin, are a common, effective, and generally well-tolerated form of contraception with a wide variety of noncontraceptive benefits. Combined oral contraceptives have been most limited by the potential severe adverse event of venous thromboembolism throughout their history and development. In recent years, natural-estrogen\u2013containing COCs have emerged with an improved safety profile while maintaining high efficacy and should likely be recommended as first line for new-start patients. It is important for clinicians to understand the evolution of COC regimens and the specific hormones within each formulation to best optimize benefits while minimizing risks to patients.<\/jats:p>","DOI":"10.1097\/aog.0000000000006424","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:00:50Z","timestamp":1788465650000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Combined Oral Contraception"],"prefix":"10.1097","author":[{"given":"Ciara E.","family":"Hutchison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell D.","family":"Creinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"R1-20260903","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2307\/2133987","article-title":"Trends in contraceptive practice: 1965-1973","volume":"8","author":"Westoff","year":"1976","journal-title":"Fam Plann Perspect"},{"key":"R2-20260903","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2105\/AJPH.75.10.1173","article-title":"Prevalence and trends in oral contraceptive use in premenopausal females ages 12-54 years, United States, 1971-80","volume":"75","author":"Russell-Briefel","year":"1985","journal-title":"Am J Public Health"},{"key":"R3-20260903","first-page":"587","article-title":"Trends in oral contraceptive and intrauterine device use among reproductive-aged women in the US from 1999 to 2017","volume":"32","author":"King","year":"2021","journal-title":"Cancer Causes Control"},{"key":"R4-20260903","first-page":"10.15620\/cdc\/174618","article-title":"Current contraceptive status among females ages 15\u201349: United States, 2022\u20132023","year":"2025","journal-title":"NCHS Data Brief"},{"key":"R5-20260903","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2020.05.017","article-title":"Oral contraceptive generations\u2014time to stop using a marketing myth to define nomenclature","volume":"102","author":"Creinin","year":"2020","journal-title":"Contraception"},{"key":"R6-20260903","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1152\/japplphysiol.00346.2023","article-title":"Menstrual cycle hormones and oral contraceptives: a multimethod systems physiology-based review of their impact on key aspects of female physiology","volume":"135","author":"D'Souza","year":"2023","journal-title":"J Appl Physiol (1985)"},{"key":"R7-20260903","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9378(99)70720-9","article-title":"Update on androgenicity","volume":"180","author":"Thorneycroft","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20260903","doi-asserted-by":"crossref","first-page":"119091","DOI":"10.1016\/j.lfs.2021.119091","article-title":"Estrogens as regulator of hematopoietic stem cell, immune cells and bone biology","volume":"269","author":"Kumar","year":"2021","journal-title":"Life Sci"},{"key":"R9-20260903","doi-asserted-by":"crossref","first-page":"106539","DOI":"10.1016\/j.jsbmb.2024.106539","article-title":"Metabolism of endogenous and exogenous estrogens in women","volume":"242","author":"Stanczyk","year":"2024","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R11-20260903","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/0002-9378(90)90554-K","article-title":"Gastrointestinal metabolism of contraceptive steroids","volume":"163","author":"Back","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20260903","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1345\/aph.1Q216","article-title":"Estradiol valerate\/dienogest: a novel oral contraceptive","volume":"45","author":"Whalen","year":"2011","journal-title":"Ann Pharmacother"},{"key":"R13-20260903","doi-asserted-by":"crossref","first-page":"110310","DOI":"10.1016\/j.contraception.2023.110310","article-title":"Comparison of estrogenic components used for hormonal contraception","volume":"130","author":"Stanczyk","year":"2024","journal-title":"Contraception"},{"key":"R14-20260903","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"R16-20260903","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"R17-20260903","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0010-7824(90)90093-B","article-title":"Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids","volume":"42","author":"Stanczyk","year":"1990","journal-title":"Contraception"},{"key":"R19-20260903","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1210\/jc.2007-0044","article-title":"Formation of ethinyl estradiol in women during treatment with norethindrone acetate","volume":"92","author":"Chu","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20260903","doi-asserted-by":"crossref","first-page":"1730768","DOI":"10.3389\/fendo.2026.1730768","article-title":"A detailed review of pharmacokinetics\/pharmacodynamics of progestogens in oral contraception","volume":"17","author":"Gaspard","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R21-20260903","first-page":"S12","article-title":"History of oral contraception","volume":"15","author":"Dhont","year":"2010"},{"key":"R22-20260903","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(61)91061-3","article-title":"Pulmonary embolism","volume":"278","author":"Jordan","year":"1961","journal-title":"Lancet"},{"key":"R23-20260903","first-page":"CD003553","article-title":"Triphasic versus monophasic oral contraceptives for contraception","author":"Van Vliet","year":"2011","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R24-20260903","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.2174\/156802610793176666","article-title":"The Hatch-Waxman Act: encouraging innovation and generic drug competition","volume":"10","author":"Sokal","year":"2010","journal-title":"Curr Top Med Chem"},{"key":"R25-20260903","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.AOG.0000263922.08190.3b","article-title":"Brand versus generic oral contraceptives. ACOG Committee Opinion No. 375. American College of Obstetricians & Gynecologists","volume":"110","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R26-20260903","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/humupd\/5.6.621","article-title":"The public health implications of the 1995 \u201cpill scare","volume":"5","author":"Furedi","year":"1999","journal-title":"Hum Reprod Update"},{"key":"R27-20260903","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: phase 3 study results","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"R28-20260903","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/PPA.S3692","article-title":"Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel\/ethinylestradiol oral contraceptives","volume":"3","author":"Benagiano","year":"2009","journal-title":"Patient Prefer Adherence"},{"issue":"(suppl)","key":"R29-20260903","first-page":"721","article-title":"YAZ and the novel progestin drospirenone","volume":"53","author":"Mishell","year":"2008","journal-title":"J Reprod Med"},{"key":"R30-20260903","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.contraception.2013.09.007","article-title":"Comparison of pregnancy rates in users of extended and cyclic combined oral contraceptive (COC) regimens in the United States: a brief report","volume":"89","author":"Howard","year":"2014","journal-title":"Contraception"},{"key":"R31-20260903","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception","author":"Edelman","year":"2014","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R33-20260903","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"key":"R35-20260903","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17512433.2022.2054413","article-title":"Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause","volume":"15","author":"G\u00e9rard","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R36-20260903","doi-asserted-by":"crossref","first-page":"8832","DOI":"10.3390\/jcm14248832","article-title":"Multicentre trial evaluating the safety and tolerability of estetrol-drospirenone combined oral contraceptive in postmenarchal female adolescents","volume":"14","author":"Lind\u00e9n Hirschberg","year":"2025","journal-title":"J Clin Med"},{"key":"R37-20260903","doi-asserted-by":"crossref","first-page":"110140","DOI":"10.1016\/j.contraception.2023.110140","article-title":"Contraceptive efficacy should primarily be measured using life table pregnancy rates","volume":"127","author":"Mauck","year":"2023","journal-title":"Contraception"},{"key":"R38-20260903","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.contraception.2013.04.001","article-title":"The creeping pearl: why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?","volume":"88","author":"Trussell","year":"2013","journal-title":"Contraception"},{"key":"R39-20260903","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/AOG.0000000000005155","article-title":"Combined oral contraceptive adherence and pregnancy rates","volume":"141","author":"Creinin","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R40-20260903","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2006.12.018","article-title":"Range of published estimates of venous thromboembolism incidence in young women","volume":"75","author":"Heinemann","year":"2007","journal-title":"Contraception"},{"key":"R41-20260903","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jth.12224","article-title":"Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?","volume":"11","author":"Bird","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R42-20260903","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/1471-0528.16840","article-title":"Estetrol-drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia","volume":"129","author":"Gemzell-Danielsson","year":"2022","journal-title":"BJOG"},{"key":"R43-20260903","doi-asserted-by":"crossref","first-page":"1428597","DOI":"10.3389\/fendo.2024.1428597","article-title":"Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis","volume":"15","author":"Douxfils","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R44-20260903","doi-asserted-by":"crossref","first-page":"110727","DOI":"10.1016\/j.contraception.2024.110727","article-title":"Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills: a disproportionality analysis of the Eudravigilance database","volume":"142","author":"Didembourg","year":"2025","journal-title":"Contraception"},{"key":"R45-20260903","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajog.2026.02.046","article-title":"Venous thromboembolism with combined oral contraceptives based on estrogen and progestin content: a disproportionality analysis of the United States Food and Drug Administration Adverse Event Reporting System Database","volume":"235","author":"Raskin","year":"2026","journal-title":"Am J Obstet Gynecol"},{"key":"R46-20260903","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/17512433.2017.1356718","article-title":"Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2: effects on hemostasis","volume":"10","author":"Farris","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R47-20260903","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"R48-20260903","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/13625180008500383","article-title":"Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?","volume":"5","author":"Spannagl","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R49-20260903","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0015-0282(99)00318-0","article-title":"Screening for factor V Leiden mutation before prescribing combination oral contraceptives","volume":"72","author":"Creinin","year":"1999","journal-title":"Fertil Steril"},{"key":"R50-20260903","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.122.20018","article-title":"Oral contraceptive pills and hypertension: a review of current evidence and recommendations","volume":"80","author":"Cameron","year":"2023","journal-title":"Hypertension"},{"key":"R51-20260903","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00004872-199715100-00003","article-title":"Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994","volume":"15","author":"Dong","year":"1997","journal-title":"J Hypertens"},{"key":"R52-20260903","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2007.01.007","article-title":"Use of oral contraceptives in Germany: prevalence, determinants and use-associated health correlates: results of National Health Surveys from 1984 to 1999","volume":"134","author":"Du","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R53-20260903","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1472-6874-13-39","article-title":"Associations between oral contraceptive use and risks of hypertension and prehypertension in a cross-sectional study of Korean women","volume":"13","author":"Park","year":"2013","journal-title":"BMC Womens Health"},{"key":"R54-20260903","first-page":"643","article-title":"Effect of oral contraceptive therapy on the renin-angiotensin system in normotensive and hypertensive women","volume":"41","author":"Apia","year":"1973","journal-title":"Obstet Gynecol"},{"key":"R55-20260903","first-page":"145","article-title":"A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel","volume":"4","author":"Winkler","year":"1999"},{"key":"R56-20260903","doi-asserted-by":"crossref","first-page":"110861","DOI":"10.1016\/j.contraception.2025.110861","article-title":"Estetrol\/drospirenone safety in a population with cardiovascular risk factors","volume":"146","author":"Creinin","year":"2025","journal-title":"Contraception"},{"key":"R57-20260903","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0010-7824(01)00306-7","article-title":"Contraceptives and cerebral thrombosis: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"R58-20260903","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3949\/ccjm.84a.16033","article-title":"Combined hormonal contraceptives and migraine: an update on the evidence","volume":"84","author":"Calhoun","year":"2017","journal-title":"Cleve Clin J Med"},{"key":"R59-20260903","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/AOG.0000000000006335","article-title":"Modernizing the analysis of migraine with aura, oral contraceptives, and risk of stroke","volume":"148","author":"Fang","year":"2026","journal-title":"Obstet Gynecol"},{"key":"R60-20260903","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/S0010-7824(15)30002-0","article-title":"Breast cancer and hormonal contraceptives: further results","volume":"54","author":"Calle","year":"1996","journal-title":"Contraception"},{"key":"R61-20260903","first-page":"1375","article-title":"Use of oral contraceptives and breast cancer risk: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study","volume":"11","author":"Kumle","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R62-20260903","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2012.05.008","article-title":"Cancer and contraception: SFP guideline #20121","volume":"86","author":"Patel","year":"2012","journal-title":"Contraception"},{"key":"R64-20260903","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajog.2015.07.044","article-title":"The medical management of abnormal uterine bleeding in reproductive-aged women","volume":"214","author":"Bradley","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R65-20260903","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.AOG.0000199950.64545.16","article-title":"Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?","volume":"107","author":"Edelman","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R66-20260903","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/AOG.0000000000004096","article-title":"Primary dysmenorrhea: diagnosis and therapy","volume":"136","author":"Ferries-Rowe","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R67-20260903","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.2025.2975","article-title":"Endometriosis: a review","volume":"334","author":"As-Sanie","year":"2025","journal-title":"JAMA"},{"key":"R68-20260903","first-page":"CD002120","article-title":"Combined oral contraceptive pill for primary dysmenorrhoea","volume":"7","author":"Schroll","year":"2023","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R69-20260903","first-page":"CD001019","article-title":"Oral contraceptives for pain associated with endometriosis","volume":"5","author":"Brown","year":"2018","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R70-20260903","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.fertnstert.2024.11.003","article-title":"Efficacy and safety of estetrol (15 mg)\/drospirenone (3 mg) combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: a multicenter, placebo-controlled, double-blind, randomized study","volume":"123","author":"Osuga","year":"2025","journal-title":"Fertil Steril"},{"key":"R71-20260903","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.fertnstert.2024.07.011","article-title":"Efficacy and safety of the combination of estetrol 15 mg\/drospirenone 3 mg in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: a multicenter, placebo-controlled, double-blind, randomized study","volume":"122","author":"Harada","year":"2024","journal-title":"Fertil Steril"},{"key":"R72-20260903","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(08)60527-9","article-title":"Premenstrual syndrome","volume":"371","author":"Yonkers","year":"2008","journal-title":"Lancet."},{"key":"R73-20260903","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/aogs.15043","article-title":"Association of oral contraceptives and risk of endometrial cancer: a systematic review and meta-analysis","volume":"104","author":"Harajka","year":"2025","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R74-20260903","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1158\/0008-5472.CAN-20-2476","article-title":"Time-dependent effects of oral contraceptive use on breast, ovarian, and endometrial cancers","volume":"81","author":"Karlsson","year":"2021","journal-title":"Cancer Res"},{"key":"R75-20260903","doi-asserted-by":"crossref","first-page":"1006.e1","DOI":"10.1016\/j.jaad.2023.12.017","article-title":"Guidelines of care for the management of acne vulgaris","volume":"90","author":"Reynolds","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"R76-20260903","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2012","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R77-20260903","first-page":"CD005552","article-title":"Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome","volume":"8","author":"Fraison","year":"2020","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R78-20260903","first-page":"1015","article-title":"Oral contraceptives for the prevention of osteoporosis","volume":"38","author":"Corson","year":"1993","journal-title":"J Reprod Med"},{"key":"R79-20260903","first-page":"CD003987","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2014","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R80-20260903","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.contraception.2012.09.010","article-title":"When can a woman start combined hormonal contraceptives (CHCs)? A systematic review","volume":"87","author":"Brahmi","year":"2013","journal-title":"Contraception"},{"key":"R81-20260903","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7303a1","article-title":"U.S. selected practice recommendations for contraceptive use, 2024","volume":"73","author":"Curtis","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"R82-20260903","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.contraception.2015.05.006","article-title":"Combined hormonal contraceptive use among breastfeeding women: an updated systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"R83-20260903","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:01:00Z","timestamp":1788465660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":77,"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006424","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"2026-05-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}